Q1 2026 · 13F-HR/A
PERCEPTIVE ADVISORS LLCholdings as filed
Filed 2026-05-29 · accession 0001012975-26-000499
$5.12B
Reported value
94
Positions
2026-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $656.0M | 12.8% | 2,035,986 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $356.9M | 6.97% | 3,127,200 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $350.3M | 6.84% | 1,531,421 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $229.5M | 4.48% | 8,285,461 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $208.9M | 4.08% | 5,258,903 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $206.4M | 4.03% | 2,373,795 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $190.8M | 3.73% | 3,783,225 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $161.9M | 3.16% | 1,580,505 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $139.4M | 2.72% | 4,423,974 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $129.7M | 2.54% | 1,230,879 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $129.7M | 2.53% | 1,540,384 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $123.1M | 2.40% | 4,142,551 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $115.2M | 2.25% | 8,284,882 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $102.2M | 2.00% | 10,383,456 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $97.0M | 1.90% | 9,751,141 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $97.0M | 1.90% | 1,442,707 | Common | SOLE |
| G59665102 | MGTX | MEIRAGTX HLDGS PLC | $89.3M | 1.75% | 10,326,103 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $87.9M | 1.72% | 3,510,078 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $85.7M | 1.68% | 11,906,646 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $84.6M | 1.65% | 4,668,839 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $70.8M | 1.38% | 7,434,033 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $68.4M | 1.34% | 1,395,501 | Common | SOLE |
| 228903100 | AORT | ARTIVION INC | $60.0M | 1.17% | 1,637,290 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $57.5M | 1.12% | 3,710,877 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $50.8M | 0.99% | 1,000,000 | PUT | SOLE |
| 63909J108 | NAUT | NAUTILUS BIOTECHNOLOGY INC | $48.9M | 0.95% | 12,594,211 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC. | $47.5M | 0.93% | 10,098,824 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $45.2M | 0.88% | 2,009,893 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $39.7M | 0.78% | 5,827,506 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $39.7M | 0.78% | 1,597,383 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $39.4M | 0.77% | 85,419 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $37.8M | 0.74% | 504,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $37.6M | 0.74% | 1,755,799 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $36.6M | 0.72% | 328,884 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $33.5M | 0.66% | 2,292,441 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $33.1M | 0.65% | 280,541 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $32.1M | 0.63% | 170,000 | Common | SOLE |
| 36322Q206 | DMRA | DAMORA THERAPEUTICS INC | $31.7M | 0.62% | 1,223,000 | Common | SOLE |
| 98420X202 | XFOR | X4 PHARMACEUTICALS INC | $27.8M | 0.54% | 6,737,648 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $27.7M | 0.54% | 300,000 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $27.5M | 0.54% | 377,544 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $27.1M | 0.53% | 20,859,303 | Common | SOLE |
| 829401108 | SION | SIONNA THERAPEUTICS INC | $26.4M | 0.52% | 658,439 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC. | $25.3M | 0.50% | 149,950 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $25.1M | 0.49% | 258,600 | Common | SOLE |
| 78397T202 | SABS | SAB BIOTHERAPEUTICS INC | $24.6M | 0.48% | 6,431,743 | Common | SOLE |
| 07782B104 | BLTE | BELITE BIO INC | $24.2M | 0.47% | 151,979 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $23.2M | 0.45% | 1,447,782 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $23.1M | 0.45% | 697,312 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $22.9M | 0.45% | 1,170,829 | Common | SOLE |
| 68572M106 | OBIO | ORCHESTRA BIOMED HLDGS INC | $21.4M | 0.42% | 5,037,906 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS INC | $21.1M | 0.41% | 673,923 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $20.1M | 0.39% | 964,391 | Common | SOLE |
| 04746L203 | LONA | LEONABIO INC | $19.1M | 0.37% | 1,859,322 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $19.0M | 0.37% | 3,425,476 | Common | SOLE |
| 869367201 | STRO | SUTRO BIOPHARMA INC | $17.8M | 0.35% | 715,307 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $16.9M | 0.33% | 808,153 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $16.4M | 0.32% | 1,255,592 | Common | SOLE |
| 15102KAA8 | CELC 2.75 08/01/31 | CELCUITY INC | $15.9M | 0.31% | 6,500,000 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $15.6M | 0.31% | 8,928,149 | Common | SOLE |
| H5870P102 | OCS | OCULIS HOLDING AG | $13.1M | 0.26% | 493,827 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM HOLDINGS INC | $12.4M | 0.24% | 105,026 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $11.0M | 0.22% | 9,876,576 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $10.3M | 0.20% | 448,350 | Common | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $10.3M | 0.20% | 925,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $10.0M | 0.19% | 5,104,097 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $9.9M | 0.19% | 786,330 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $8.6M | 0.17% | 65,050 | Common | SOLE |
| 08659B102 | BBNX | BETA BIONICS INC | $8.4M | 0.17% | 842,944 | Common | SOLE |
| 67577R102 | IRD | OPUS GENETICS INC | $8.4M | 0.16% | 1,835,842 | Common | SOLE |
| 090168105 | BLLN | BILLIONTOONE INC | $7.2M | 0.14% | 91,812 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $7.1M | 0.14% | 150,000 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $6.7M | 0.13% | 229,393 | Common | SOLE |
| 00860C102 | AGMB | AGOMAB THERAPEUTICS NV | $6.3M | 0.12% | 600,000 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $5.3M | 0.10% | 1,286,862 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $4.7M | 0.09% | 121,082 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $4.2M | 0.08% | 500,000 | CALL | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $4.2M | 0.08% | 467,233 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $3.9M | 0.08% | 2,315,000 | Common | SOLE |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $3.8M | 0.07% | 206,942 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.3M | 0.06% | 80,956 | Common | SOLE |
| 690145206 | OM | OUTSET MED INC | $3.2M | 0.06% | 833,333 | Common | SOLE |
| 27966L306 | EDSA | EDESA BIOTECH INC | $2.9M | 0.06% | 563,239 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $2.1M | 0.04% | 152,500 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $2.1M | 0.04% | 139,667 | Common | SOLE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $2.1M | 0.04% | 792,696 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $2.0M | 0.04% | 50,000 | Common | SOLE |
| 58507V107 | MDLN | MEDLINE INC | $1.2M | 0.02% | 28,000 | Common | SOLE |
| 696077601 | PTN | PALATIN TECHNOLOGIES INC | $1.1M | 0.02% | 61,945 | Common | SOLE |
| 230770109 | CPIX | CUMBERLAND PHARMACEUTICALS I | $640,179 | 0.01% | 196,978 | Common | SOLE |
| 76155X118 | RVMDW | REVOLUTION MEDICINES INC | $447,500 | 0.01% | 250,000 | Common | SOLE |
| 30068X103 | XGN | EXAGEN INC | $344,679 | 0.01% | 114,893 | Common | SOLE |
| 293602504 | ENSC | ENSYSCE BIOSCIENCES INC | $46,670 | 0.00% | 86,666 | Common | SOLE |
| 86889P117 | SRZNW | SURROZEN INC | $2,667 | 0.00% | 166,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.